Risk Assessment in a Pharmaceutical Company

Case study

Table of Contents
Contents
INTRODUCTION...........................................................................................................................1
MAIN BODY...................................................................................................................................1
Identify the hazards present and those at risk from hazards.......................................................1
Developing risk register and risk matrix and link them with the company’s strategy to ensure
safety in the business enterprise environment.............................................................................2
Analyse the robustness of the risk assessment plan to reduce the errors and mitigate the risk. .3
Recognise the role of technology in using information to reduce the errors..............................4
Evaluate the efficacy of the risk assessment plan and comment on overall success of
company’s strategy in ensuring safety........................................................................................4
CONCLUSION................................................................................................................................5
REFERENCES................................................................................................................................6

INTRODUCTION
Working safely with hazardous chemicals within a pharmaceutical company is the most
essential prospect as with this its associated risk also required to control as with this working
with dangerous substance is processed with adequateness. In this health and safety strategies
those are involved with consideration of adequate legislation through which risk abilities and
implementation of safety measure is induced in timely frame (Aylward, 2018). The report below
is based on the case study of Genera that is originated date back foundation of Royal Croatian
Slavonian Bacteriological institute in the year 1901. In the second half, company become a part
of Dechra Pharmaceutical plc group. The report below include risk from hazards, risk register
and risk matrix in terms to ensure safety in enterprise, robustness of risk assessment and
efficiency to plan risk assessment as with this adequate strategy are developed to ensure safety.
MAIN BODY
Identify the hazards present and those at risk from hazards
Genera is getting engaged and involved with production, research and development, sales
and marketing of veterinary medicines through which a range of animal care products are feed as
per concern of different activities. There are about 220 workers and in this 75% are women and
they worked more towards enhancement of production in this quality and laboratories get
controlled with timely frame. In order to coordinate with the actions, it is required that
continuous level of advancement and modification is induced under which larger amount of
chemicals are controlled with relation to active substance of around 87000 kg. In relation to EU
and Croatian health and safety rules effective and efficient management is processed in adequate
manner (Camuffo, 2019). In this chemicals get identified and controlled within the working
place as by identifying risk under which safety data sheet is maintained. In addition, risk
notification within the working place is used as per concern of pictogram through which short
instruction and accurate guidance is provided about to maintain health and safe working
surround.
The risk related to infrastructural measure and technical processing as with this operation
and its working tendency get advanced. Moreover, monitoring and controlling of risk through
which modified control over chemical concentration is maintained as under this periodically
manage of technology is managed. The personal protective equipment provision is required to
1